Schlegel Nicolas, Kim Mia, Reibetanz Joachim, Krajinovic Katica, Germer Christoph-Thomas, Isbert Christoph
Department of General-, Visceral-, Vascular and Pediatric Surgery, University Hospital Wuerzburg, Oberdürrbacherstraße 6, 97080, Wuerzburg, Germany,
Int J Colorectal Dis. 2015 May;30(5):655-63. doi: 10.1007/s00384-015-2201-2. Epub 2015 Apr 8.
Long-standing fistulizing and stenotic proctitis (LFSP) in Crohn's disease (CD) indicates the end stage of the disease. Definitive diversion such as proctectomy is considered to be the only surgical option. The impact of intersphincteric sphincter-sparing anterior rectal resection (IAR) as an alternative to proctectomy is unclear. The aim of this study was to evaluate feasibility, morbidity, outcome, and quality of life (QL) in patients with LFSP undergoing intended IAR.
Out of a single institution database, 15 patients with LFSP intended for surgery from 856 patients with CD were selected for follow-up analyses.
In 12/15 cases, IAR was carried out while 3/15 patients underwent primary proctectomy due to malignancy (n = 2) or due to patient's wish (n = 1). In one case, IAR revealed unexpected malignancy, which led to secondary proctectomy. In patients with IAR, complete healing of fistulas and stenosis was observed in 46% (n = 5) while 36% (n = 4) of patients showed relapse of fistula and 18% (n = 2) developed restenosis. Ileostomy closure was performed in seven patients from which six patients remained stoma free. QL and fecal incontinence measured by standardized scoring systems were unchanged while stool frequency was reduced after IAR in patients with ileostomy closure. The rate of malignancy in this cohort was 20% (n = 3).
LFSP in CD was associated with 20% of malignant transformation. Although IAR fails to improve QL, it is a suitable procedure for the treatment of fistulas and stenosis associated with acceptable healing rates and can avoid a permanent stoma.
克罗恩病(CD)中的长期瘘管性和狭窄性直肠炎(LFSP)表明疾病处于终末期。诸如直肠切除术等确定性转流术被认为是唯一的手术选择。作为直肠切除术替代方案的括约肌间保留括约肌前直肠切除术(IAR)的影响尚不清楚。本研究的目的是评估接受意向性IAR的LFSP患者的可行性、发病率、结局和生活质量(QL)。
从一个单一机构数据库中,从856例CD患者中选择15例拟行手术的LFSP患者进行随访分析。
15例患者中,12例进行了IAR,3例因恶性肿瘤(n = 2)或患者意愿(n = 1)接受了一期直肠切除术。1例患者IAR术中发现意外恶性肿瘤,导致二期直肠切除术。接受IAR的患者中,46%(n = 5)的瘘管和狭窄完全愈合,36%(n = 4)的患者瘘管复发,18%(n = 2)出现再狭窄。7例患者进行了回肠造口关闭术,其中6例患者不再有造口。通过标准化评分系统测量的QL和大便失禁情况未改变,而回肠造口关闭的患者IAR后排便频率降低。该队列中的恶性肿瘤发生率为20%(n = 3)。
CD中的LFSP与20%的恶性转化相关。虽然IAR未能改善QL,但它是治疗瘘管和狭窄的合适手术,愈合率可接受,且可避免永久性造口。